| Name: | Bendamustine Related Compound G |
| Catalogue No. | VL1450012 |
| CAS No. | N/A |
| Molecular Formula | C16H21Cl2N3O2S |
| Molecular Weight | 390.33 |
| Status | In-stock |
| IUPAC Name | (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride) |
| Synonyms | Bendamustine Related Compound 02 |
| Appearance | brown color powder |
| Description | Bendamustine Related Compound G ( CAS No: N/A ) or 4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid HCl is the associate impurity of Bendamustine. Bendamustine is employed for the treatment of chronic cancer of the blood (CLL). |
| References | “Sci-Hub | Bendamustine: Rebirth of an Old Drug | 10.1200/Jco.2008.18.7252.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1200/jco.2008.18.7252. |
